Ortek develops two oral health products aimed at early cavity detection and enamel health. The Ortek-ECD is a FDA-cleared handheld device that measures the electrical conductance of enamel to detect early cavities on the biting surfaces of back teeth. It is a portable, point-of-care diagnostic tool with a base unit and disposable stainless steel tips, designed to complement X-rays by identifying lesions that may be missed in early stages. The ECD is used by dental professionals and has been adopted by hundreds of dentists in the United States.

BasicBites are sugar-free soft chews that leverage an oral microbiome approach to support enamel health. Available in chocolate and caramel, two chews per day are clinically shown to help maintain enamel health. The product contains arginine bicarbonate to support beneficial bacteria and a healthier oral pH environment, aiding calcium carbonate in enamel fortification. BasicBites have been on the market since 2014 and have accumulated over $1 million in cumulative sales with a limited marketing budget.

Ortek holds worldwide patent protection for the ECD and has two patent-pending variants for BasicBites. The company has a strategic alliance with The Research Foundation for The State University of New York and with researchers at Stony Brook University School of Dental Medicine, linking to exclusive licenses for two skin microbiome technologies intended for topical consumer and pharmaceutical products. BasicBites and related lines also pursue additional patent activity.

The market context indicates a large and growing global dental and oral care sector. The global dental services market has been valued in the hundreds of billions of dollars and is projected to grow toward the high end of that range by 2030; the dental equipment market is also sizable and expanding. An estimated portion of the global population experiences tooth decay, with particular prevalence in back teeth where X-rays may be less effective. In the United States, the dentist base is substantial (approximately 200,000 domestically; nearly 1 million globally), presenting a sizable addressable audience for ECD deployments and consumer products like BasicBites. The company intends to scale commercialization through expanded marketing, professional education, and broader adoption across dental offices and consumer channels.